Abstract
PURPOSE: Puborectalis syndrome has been difficult to treat. We investigated the efficacy of botulinum toxin in treating patients with puborectalis syndrome who had previously failed to respond to electromyographic biofeedback sessions and who refused to use anal dilators. METHODS: Of a group of 50 patients with chronic outlet obstruction constipation, four patients with puborectalis syndrome were included in the study. The patients were studied using anorectal manometry, defecography, and electromyography and then treated with 30 units of Type A botulinum toxin, injected into two sites on either side of the puborectalis muscle, under ultrasonographic guidance. RESULTS: One patient was lost to follow-up. After treatment in other patients, the frequency of natural bowel movements increased from zero to six per week and laxatives were needed by only one patient. Anorectal manometry demonstrated decreased tone during straining from (mean ± standard deviation) 96.2 ± 12 mmHg to 42.5 ± 13 mmHg at four weeks (P=0.003) and 63.2 ± 22 mmHg at eight weeks (P=0.009). Defecography performed eight weeks after treatment showed improvement in the anorectal angle, which increased from 94 ± 11° to 114 ± 13° (P=0.01), and evacuation of barium paste. Electromyography demonstrated mild paradoxical contraction. However, 16 weeks after treatment one of these three patients suffered symptomatic recurrence. This patient was re-treated with 50 units of toxin; eight months later he required a further 60 units. Seven months after the last injection he reported normal daily bowel movements without the use of laxatives. CONCLUSIONS: Botulinum toxin injection should be considered as a simple therapeutic approach in patients with puborectalis syndrome. The use of higher dosage and a more precise method of toxin injections under transrectal ultrasonography account for the long-term higher success rate. However, because the effects of the toxin wear off within three months of administration, repeated injections could be necessary to maintain the clinical improvement.
Similar content being viewed by others
References
Wexner SD, Bartolo DC. Constipation. Etiology, evaluation and management. Oxford: Butterworth-Heinemann, 1995.
Barnes PR, Hawley PR, Preston DM, Lennard-Jones JE. Experience of posterior division of the puborectal muscle in the management of chronic constipation. Br J Surg 1985;72:475–7.
Wallace WC, Madden WM. Partial puborectalis resection. A new surgical technique for anorectal dysfunction. South Med J 1969;62:1123–6.
Kamm MA, Hawley PR, Lennard-Jones JE. Lateral division of the puborectalis muscle in the management of severe constipation. Br J Surg 1988;75:661–3.
Maria G, Anastasio G, Brisinda G, Civello IM. Treatment of puborectalis syndrome with progressive anal dilation. Dis Colon Rectum 1997;40:89–92.
Park UC, Choi SK, Piccirillo MF, Verzaro R, Wexner SD. Patterns of anismus and the relation to biofeedback therapy. Dis Colon Rectum 1996;39:768–73.
Gilliland R, Heymen S, Altomare DF, Park UC, Vickers D, Wexner SD. Outcome and predictors of success of biofeedback for constipation. Br J Surg 1997;84:1123–6.
Hallan RI, Williams NS, Melling J, Waldron DJ, Womack NR, Morrison JF. Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 1988;338:714–7.
Joo JS, Agachan F, Wolff B, Nogueras JJ, Wexner SD. Initial North American experience with botulinum toxin Type A for treatment of anismus. Dis Colon Rectum 1996;39:1107–11.
Maria G, Anastasio G, Brisinda G, Liberatore E, Civello IM. Severe chronic constipation: our experience concerning diagnostic examinations. Coloproctology 1995;17:105–10.
Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186–94.
Bhutani MS. Gastrointestinal uses of botulinum toxin. Am J Gastroenterol 1997;92:929–33.
Albanese A, Bentivoglio AR, Cassetta E, Viggiano A, Maria G, Gui D. The use of botulinum toxin on the alimentary tract. Aliment Pharmacol Ther 1995;9:599–604.
Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline injection for treatment of chronic anal fissure. N Engl J Med 1998;338:217–20.
Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure. Long-term results after two different dose regimens. Ann Surg 1998;228:664–9.
Albanese A, Maria G, Bentivoglio AR, Brisinda G, Cassetta E, Tonali P. Severe constipation in Parkinson's disease relieved by botulinum toxin. Mov Disord 1997;12:764–6.
Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord 1997;12:89–94.
Author information
Authors and Affiliations
About this article
Cite this article
Maria, G., Brisinda, G., Bentivoglio, A.R. et al. Botulinum toxin in the treatment of outlet obstruction constipation caused by puborectalis syndrome. Dis Colon Rectum 43, 376–380 (2000). https://doi.org/10.1007/BF02258305
Issue Date:
DOI: https://doi.org/10.1007/BF02258305